MEDPLUS HEALTH SERV LTD Fair Value
MEDPLUS · Consumer Services · Current price ₹674.6
| Method | Fair value | Status |
|---|---|---|
| Residual income | ₹166 | 12% ROE fading to 12% over ~3 yrs, on ₹165 book |
| Relative P/E | ₹1,285 | EPS × 70.2 peer-median P/E |
| Graham floor | ₹261 | Conservative floor: √(22.5 × EPS × book value/share) |
| Analyst target | ₹1,013 | Street consensus 12-month target price |
Is MEDPLUS HEALTH SERV LTD undervalued?
DocStoX estimates the fair value of MEDPLUS HEALTH SERV LTD at ₹588 per share, versus the current market price of ₹675. That puts the stock about -12.8% above our fair-value estimate, which we read as "Fairly Valued". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 4 independent methods: Residual income (₹166), Relative P/E (₹1,285), Graham floor (₹261), Analyst target (₹1,013). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹166 (bear) to ₹588 (base) to ₹1,285 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
More on MEDPLUS HEALTH SERV LTD
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.